Published in Am J Gastroenterol on February 09, 2010
Impact of pediatric inflammatory bowel disease on linear growth: Data from a national cohort study in Saudi Arabia. Saudi J Gastroenterol (2016) 1.14
Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol (2012) 1.05
Exclusive enteral nutrition in children with Crohn's disease. World J Gastroenterol (2015) 0.90
Crohn's disease and growth deficiency in children and adolescents. World J Gastroenterol (2014) 0.88
Advances in nutritional therapy in inflammatory bowel diseases: Review. World J Gastroenterol (2016) 0.86
Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains. J Pediatr (2013) 0.86
Sex differences in statural growth impairment in Crohn's disease: role of IGF-1. Inflamm Bowel Dis (2011) 0.85
Current issues of pediatric inflammatory bowel disease in Korea. Korean J Pediatr (2014) 0.82
Detailed assessment of nutritional status and eating patterns in children with gastrointestinal diseases attending an outpatients clinic and contemporary healthy controls. Eur J Clin Nutr (2014) 0.78
Body composition as an indicator of the nutritional status in children with newly diagnosed ulcerative colitis and Crohn's disease - a prospective study. Prz Gastroenterol (2016) 0.75
Summary of "Growth and nutritional status in pediatric Crohn's disease" with a focus on sex differences in statural growth impairment. J Pediatr Gastroenterol Nutr (2011) 0.75
Gender differences in paediatric patients of the swiss inflammatory bowel disease cohort study. Pediatr Gastroenterol Hepatol Nutr (2014) 0.75
Nutritional status of children with inflammatory bowel disease in Saudi Arabia. World J Gastroenterol (2016) 0.75
Nutritional perspectives of children with Crohn's disease: a single-centre cohort observation of disease activity, energy expenditure and dietary intake. Eur J Clin Nutr (2016) 0.75
NASPGHAN single-topic symposium: discovering the future of pediatric IBD care. J Pediatr Gastroenterol Nutr (2014) 0.75
Surgery in Pediatric Crohn's Disease: Indications, Timing and Post-Operative Management. Pediatr Gastroenterol Hepatol Nutr (2017) 0.75
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet (2012) 5.12
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet (2009) 5.03
Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology (2011) 4.88
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology (2004) 4.26
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology (2011) 3.81
Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology (2013) 3.45
Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr (2005) 3.08
Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2008) 2.84
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc (2006) 2.73
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology (2005) 2.70
Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology (2008) 2.52
Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol (2008) 2.44
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med (2005) 2.06
Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol (2002) 1.94
Acute esophageal necrosis: a 1-year prospective study. Gastrointest Endosc (2002) 1.92
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut (2010) 1.87
Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology (2010) 1.73
Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr (2011) 1.67
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2012) 1.57
Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc (2006) 1.57
Breast-feeding: A commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2009) 1.55
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut (2010) 1.53
Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study. Am J Gastroenterol (2008) 1.52
Fermented infant formulae without live bacteria. J Pediatr Gastroenterol Nutr (2007) 1.51
Small bowel capsule endoscopy for management of Crohn's disease: a retrospective tertiary care centre experience. Dig Liver Dis (2012) 1.49
Gastroesophageal reflux disease and Helicobacter pylori infection in neurologically impaired children: inter-relations and therapeutic implications. J Pediatr Gastroenterol Nutr (2004) 1.46
Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr (2005) 1.45
Home enteral nutrition in children: an 11-year experience with 416 patients. Clin Nutr (2005) 1.45
Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol (2006) 1.40
Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study. Cancer Biol Ther (2009) 1.40
Longevity of balloon-stabilized skin-level gastrostomy device. J Pediatr Gastroenterol Nutr (2004) 1.39
Inflammatory pseudotumor of the cerebellum in a patient with Crohn's disease. World Neurosurg (2011) 1.39
Is a 2-liter PEG preparation useful before capsule endoscopy? J Clin Gastroenterol (2005) 1.39
Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr (2013) 1.38
Changes in characteristics and outcome of acute upper gastrointestinal haemorrhage: a comparison of epidemiology and practices between 1996 and 2000 in a multicentre French study. Eur J Gastroenterol Hepatol (2005) 1.36
The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol (2009) 1.29
Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr (2011) 1.27
Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2006) 1.26
Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr (2014) 1.25
Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis (2010) 1.23
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut (2013) 1.22
Factors that affect gastric passage of video capsule. Gastrointest Endosc (2005) 1.19
Acute hepatitis due to buprenorphine administration. Eur J Gastroenterol Hepatol (2004) 1.16
Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflamm Bowel Dis (2010) 1.15
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol (2010) 1.15
Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol (2009) 1.15
Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study. Am J Gastroenterol (2006) 1.13
Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis (2012) 1.12
Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr (2013) 1.12
Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up. J Pediatr (2010) 1.12
Surgical management of deep infiltrating endometriosis of the rectum: pleading for a symptom-guided approach. Hum Reprod (2010) 1.12
Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study. Rheumatology (Oxford) (2009) 1.11
Practical approach to paediatric enteral nutrition: a comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr (2010) 1.08
Natural history of eosinophilic gastroenteritis. Clin Gastroenterol Hepatol (2011) 1.07
Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol (2009) 1.07
Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis (2013) 1.05
Successful management of symptoms of steroid-dependent mesenteric panniculitis with colchicine. Dig Dis Sci (2006) 1.03
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Inflamm Bowel Dis (2007) 1.02
Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2004) 1.02
Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. J Clin Microbiol (2005) 1.02
Role of dietary factors and food habits in the development of childhood obesity: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2011) 1.00
Diagnostic yield and therapeutic implications of capsule endoscopy in obscure gastrointestinal bleeding. Gastroenterol Clin Biol (2004) 0.98
An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis. J Nutr (2010) 0.97
Feeding preterm infants after hospital discharge: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr (2006) 0.97
Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clin Nutr (2011) 0.96
Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis (2014) 0.95